🇺🇸 Clomifene Citrate in United States
91 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 91
Most-reported reactions
- Nausea — 13 reports (14.29%)
- Off Label Use — 12 reports (13.19%)
- Vomiting — 10 reports (10.99%)
- Headache — 9 reports (9.89%)
- Insomnia — 9 reports (9.89%)
- Ovarian Hyperstimulation Syndrome — 9 reports (9.89%)
- Abortion Spontaneous — 8 reports (8.79%)
- Drug Ineffective — 7 reports (7.69%)
- Foetal Exposure During Pregnancy — 7 reports (7.69%)
- Maternal Exposure During Pregnancy — 7 reports (7.69%)
Other Reproductive/Fertility approved in United States
Frequently asked questions
Is Clomifene Citrate approved in United States?
Clomifene Citrate does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Clomifene Citrate in United States?
Fundació Privada Eugin is the originator. The local marketing authorisation holder may differ — check the official source linked above.